CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial.

June 16, 2021
loading...
ad300
download Now

By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ
Share This
dailynews

Pellentesque vitae lectus in mauris sollicitudin ornare sit amet eget ligula. Donec pharetra, arcu eu consectetur semper, est nulla sodales risus, vel efficitur orci justo quis tellus. Phasellus sit amet est pharetra

Related Posts